wire - news in brief
Category
Results 1 - 50 of 414.
Novartis and Hewlett Packard Enterprise join forces to advance Novartis global health efforts
Novartis is collaborating with Hewlett Packard Enterprise to accelerate the use of data and digital technologies within its efforts to reimagine global health and improve access to healthcare and medicines.
Novartis is collaborating with Hewlett Packard Enterprise to accelerate the use of data and digital technologies within its efforts to reimagine global health and improve access to healthcare and medicines.
Positive survival data for Novartis investigational radioligand therapy 177Lu-PSMA-617 published in The New England Journal of Medicine
VISION manuscript shows that 177 Lu-PSMA-617 plus standard of care (SOC) significantly improved overall survival and radiographic progression-free survival for patients with metastatic castration-res
VISION manuscript shows that 177 Lu-PSMA-617 plus standard of care (SOC) significantly improved overall survival and radiographic progression-free survival for patients with metastatic castration-res
Actively Addressing Inequalities Promotes Social Change
People who have contact with other social groups are more likely to be committed to social justice. However, an international study led by the University of Zurich has shown that for this to be the case, power relations and discrimination must be actively addressed and group-specific needs must be met.
People who have contact with other social groups are more likely to be committed to social justice. However, an international study led by the University of Zurich has shown that for this to be the case, power relations and discrimination must be actively addressed and group-specific needs must be met.
Female researchers on the move
In autumn 2021 a new Centre for biomedical reseach will be inaugurated in Bellinzona. To support this event, Ticino Management features a special series of articles presenting the activities of the two main residents of the facility, IRB and IOR.
In autumn 2021 a new Centre for biomedical reseach will be inaugurated in Bellinzona. To support this event, Ticino Management features a special series of articles presenting the activities of the two main residents of the facility, IRB and IOR.
As part of his Master's degree in civil engineering, an EPFL student developed a connector for use in building sustainable structures.
Is natural always good and artificial always bad? We talked to psychologist Angela Bearth and biotechnologist Sven Panke about science, scepticism, misunderstandings and how language influences the way we think.
A cultural landscape reflects the combined activity of nature and humans. Where has the equilibrium of this union been lost? And how can we restore the balance? Putting on the VR headset, Maya finds herself immersed in a landscape where a dozen wind turbines are busy generating electricity. Whenever she moves, this immediately triggers sounds linked to the virtual image.
New Zolgensma data demonstrate age-appropriate development when used presymptomatically and rapid, clinically meaningful efficacy in symptomatic children, even those with severe SMA at baseline
All children (100%) treated presymptomatically in the SPR1NT two-copy cohort survived without respiratory or nutritional support, and sat independently for =30 seconds, most (11/14) within the WHO wi
All children (100%) treated presymptomatically in the SPR1NT two-copy cohort survived without respiratory or nutritional support, and sat independently for =30 seconds, most (11/14) within the WHO wi
Formerly widespread, native crayfish in Switzerland are now highly endangered. With support from Eawag, experts are doing everything they can to preserve the secretive river dwellers.
By studying the structure of cellular receptors and of the molecules that activate them, scientists at the Universities of Geneva and Basel are deciphering the details of immune cell activation. Chemokine receptors, located at the surface of many immune cells, play an important role in their function.
The level of self-sufficiency indicates the extent to which agricultural performance ensures food security.
EPFL has just opened a new imaging center to serve as a hub for state-of-the-art technology in imaging systems.
An EPFL Master's student has shown that artificial intelligence can be used to further automate the process of land-use classification in Switzerland, especially for rare and complicated land categories that until now have been classified manually.
State Secretary Hirayama in Portugal to attend Africa-Europe Space Earth Observation High-Level Forum and hold bilateral talks
State Secretary Martina Hirayama participated in the Africa-Europe Space Earth Observation High-Level Forum in Lisbon on 11 and 12 June.
State Secretary Martina Hirayama participated in the Africa-Europe Space Earth Observation High-Level Forum in Lisbon on 11 and 12 June.
Using chemical synthesis, Bright Peak Therapeutics can produce proteins that have never before existed.
Skewed perceptions in climate policy
The benefits of strict climate policies are often underestimated in public debate, while the costs are generally overestimated, says Lucas Bretschger. Climate protection does not have a negative impact on economic development. Climate policies will permanently affect the structures of our economies.
The benefits of strict climate policies are often underestimated in public debate, while the costs are generally overestimated, says Lucas Bretschger. Climate protection does not have a negative impact on economic development. Climate policies will permanently affect the structures of our economies.
Next week, the first European Girls' Olympiad in Informatics will take place in Zurich. The competition, which will have around 160 participants from 43 countries, is being organised by ETH students, who also came up with the original idea and are the driving force behind the event.
Novartis investigational oral therapy iptacopan (LNP023) shows benefit as monotherapy in treatment-naïve patients with rare and life-threatening blood disorder paroxysmal nocturnal hemoglobinuria
First-in-class, oral, targeted factor B inhibitor iptacopan substantially reduced both intraand extravascular hemolysis when given as monotherapy in a Phase II study of anti-C5 naïve paroxysmal noctu
First-in-class, oral, targeted factor B inhibitor iptacopan substantially reduced both intraand extravascular hemolysis when given as monotherapy in a Phase II study of anti-C5 naïve paroxysmal noctu
Roche announces data at EHA2021 reinforcing efficacy of Venclexta/Venclyxto combinations in chronic lymphocytic leukaemia and acute myeloid leukaemia
Four-year follow-up analysis from the phase III CLL14 study showed progression-free survival rate of 74.0% in previously untreated patients with chronic lymphocytic leukaemia (CLL) three years
Four-year follow-up analysis from the phase III CLL14 study showed progression-free survival rate of 74.0% in previously untreated patients with chronic lymphocytic leukaemia (CLL) three years
The R2T2 Mars Mission is an educational project developed at EPFL for grade-school and high-school classes that use the Thymio robot.
NEST to open its virtual doors
The research and innovation building NEST of Empa and Eawag can now be visited virtually at any time and from anywhere in the world.
The research and innovation building NEST of Empa and Eawag can now be visited virtually at any time and from anywhere in the world.
No room for discrimination or harassment
Discrimination and harassment violate scientific integrity - but the damage they do goes beyond that.
Discrimination and harassment violate scientific integrity - but the damage they do goes beyond that.
Novartis announces new interim analysis Phase II data for iptacopan in rare kidney disease C3 glomerulopathy (C3G)
Data shows investigational iptacopan improved estimated glomerular filtration rate (eGFR) slope and stabilized kidney function in patients with C3G 1 ; Phase III clinical trial to start in 2021 Resul
Data shows investigational iptacopan improved estimated glomerular filtration rate (eGFR) slope and stabilized kidney function in patients with C3G 1 ; Phase III clinical trial to start in 2021 Resul
The UNIGE is awarding its 3R prize to the creator of a cell model which, by reproducing a lung infection, has enabled the identification of a promising treatment. Pseudomonas aeruginosa is a bacterium responsible for many lung infections, particularly in people with cystic fibrosis or a weakened immune system.
Throughout the summer, architectural works by first-year students at EPFL's ALICE studio will be on display at four sites in Geneva Canton: Genthod, Aigues-Vertes, Vernier and Onex.
Approval for New Alzheimer’s Drug Developed at UZH
The active ingredient aducanumab, which was discovered at the University of Zurich, has been approved for use in the United States as a treatment for Alzheimer's disease.
The active ingredient aducanumab, which was discovered at the University of Zurich, has been approved for use in the United States as a treatment for Alzheimer's disease.
"Science Wire" gives access to latest science news from universities, research centers and R&D companies.Add this page to your bookmarks
